HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Haimel Selected Research

Prokaryotic Initiation Factor-2

11/2017Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Haimel Research Topics

Disease

2Hemorrhage
11/2021 - 01/2021
1hypohidrotic Ectodermal dysplasia with immune deficiency
01/2022
1Pulmonary Arterial Hypertension
01/2019
1Channelopathies
10/2018
1Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
11/2017
1Rare Diseases (Rare Disease)
11/2017
1Lymphadenopathy
11/2017

Drug/Important Bio-Agent (IBA)

1ThrombinFDA Link
11/2021
1ThrombomodulinIBA
11/2021
1A-factor (Streptomyces)IBA
01/2021
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2021
1HLA-DPB1 antigen (HLA DPB1)IBA
01/2019
1HLA-DPA1 antigen (HLA DPA1)IBA
01/2019
1PotassiumIBA
10/2018
1Phosphotransferases (Kinase)IBA
11/2017
1DNA (Deoxyribonucleic Acid)IBA
11/2017
1Carbon MonoxideIBA
11/2017
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
11/2017
1Prokaryotic Initiation Factor-2IBA
11/2017

Therapy/Procedure

1Hematopoietic Stem Cell Transplantation
01/2022